sitagliptin/metfonninhydrochlorid pharmazac 50 mg/1000 mg filmtabletten
metformin hydrochloride tablet, extended release
nucare pharmaceuticals,inc. - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus. metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. metformin hydrochloride tablets and metformin hydrochloride extended-release tablets are contraindicated in patients with: 1. severe renal impairment (egfr below 30 ml/min/1.73 m 2 ) (see warnings and precautions ). 2. known hypersensitivity to metformin hydrochloride. 3. acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin.
numeta g 13 % e emulsion zur infusion
numeta g 16 % e emulsion zur infusion
numeta g 19 % e emulsion zur infusion
amorolfin beta 50 mg/ml wirkstoffhaltiger nagellack
sitagliptin und metformin hec pharm 50 mg/1000 mg filmtabletten
sitagliptin und metformin hec pharm 50 mg/850 mg filmtabletten
amorolfin dexcel 50 mg/ml wirkstoffhaltiger nagellack
amorolfin substipharm 50 mg/ml wirkstoffhaltiger nagellack